Segmental choroidal vascularity in Acute Vogt-Koyanagi-Harada disease

急性 Vogt-Koyanagi-Harada 病中的节段性脉络膜血管

阅读:4

Abstract

PURPOSE: To analyse the changes in choroidal structures, both in the inner and outer choroid, including choroidal vascularity index (CVI) and choroidal stromal index (CSI) in patients with Vogt-Koyanagi-Harada (VKH) disease during the acute phase and after disease resolution using optical coherence tomography (OCT). METHODS: This was a retrospective, observational study of eyes with acute VKH disease. An automated image binarization protocol was used to analyse the choroid. Choroidal thickness, area, and choroidal vascular and stromal area were calculated using the same protocol. Qualitative changes in the morphology of choroidal vessels were also analysed. Changes in choroidal parameters and correlations before and after treatment were analysed. RESULTS: We included 55 eyes (29 patients) of acute VKH (9 males and 20 females). Significant reductions were observed in inner, outer, and total choroidal thickness, and in both stromal and vascular areas of the choroid after treatment (p < 0.01). However, no significant changes were noted in CVI or CSI. Additionally, 91% of eyes exhibited a horizontally oval or “slit-like” configuration of choroidal vessels following disease resolution, which was associated with a thinner choroid. On regression analysis, worse visual acuity at baseline and higher inner choroidal thickness were associated with greater improvement in visual acuity, and thinner total choroidal thickness at baseline was associated with thinner choroidal thickness at the final visit. CONCLUSION: Choroidal structural parameters in both the inner and outer choroid significantly decrease after VKH disease resolution. However, both CVI and CSI remained unchanged. Also, horizontally oval or “slit-like” choroidal vessels may be a novel OCT biomarker of resolved VKH disease. CLINICAL TRIAL REGISTRATION NUMBER: N/A

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。